Skip to main content
. 2021 May 5;29(1):1913787. doi: 10.1080/26410397.2021.1913787

Table 6.

. Causes of contraceptive switching and/or discontinuation

    Low- and middle-income countries (n = 107) High-income countries (n = 129) χ2
p-value
TOTAL
(n = 239)
What would cause cessation or discontinuation of contraceptive use Difficulties accessing methods 41 (38.3%) 84 (65.1%) <0.001 127 (53.1%)
Disapproval from clients 28 (26.2%) 14 (10.9%) 0.002 42 (17.6%)
Disapproval from spouse 21 (19.6%) 13 (10.1%) 0.038 34 (14.2%)
Disapproval from other sexual partners 13 (12.1%) 9 (7.0%) 0.174 22 (9.2%)
Disruptions to menstrual cycle 50 (46.7%) 50 (38.8%) 0.217 102 (42.7%)
Dizziness 41 (38.3%) 81 (62.8%) <0.001 124 (51.9%)
Increased bleeding 61 (57.0%) 95 (73.6%) 0.007 158 (66.1%)
Increased risk of HIV from use 53 (49.5%) 108 (83.7%) <0.001 163 (68.2%)
Increased risk of STIs from use 58 (54.2%) 111 (86.0%) <0.001 171 (71.5%)
Inconvenient to use 47 (43.9%) 77 (59.7%) 0.016 126 (52.7%)
Too expensive 34 (31.8%) 87 (67.4%) <0.001 123 (51.5%)
Nausea/vomiting 50 (46.7%) 101 (78.3%) <0.001 153 (64.0%)
Unintended pregnancy while using 50 (46.7%) 101 (78.3%) <0.001 153 (64.0%)
Weight gain or weight loss 43 (40.2%) 75 (58.1%) 0.006 120 (50.2%)
Other 2 (1.9%) 21 (16.3%) - 23 (9.6%)
a

Includes 3 respondents not reporting country of residence and omitted from analysis of country income categories.